These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 10561370

  • 1. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer.
    Nathan CO, Franklin S, Abreo FW, Nassar R, De Benedetti A, Glass J.
    J Clin Oncol; 1999 Sep; 17(9):2909-14. PubMed ID: 10561370
    [Abstract] [Full Text] [Related]

  • 2. Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers.
    Franklin S, Pho T, Abreo FW, Nassar R, De Benedetti A, Stucker FJ, Nathan CO.
    Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):177-82. PubMed ID: 10037284
    [Abstract] [Full Text] [Related]

  • 3. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer.
    Nathan CO, Liu L, Li BD, Abreo FW, Nandy I, De Benedetti A.
    Oncogene; 1997 Jul 31; 15(5):579-84. PubMed ID: 9247311
    [Abstract] [Full Text] [Related]

  • 4. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications.
    Nathan CO, Sanders K, Abreo FW, Nassar R, Glass J.
    Cancer Res; 2000 Jul 01; 60(13):3599-604. PubMed ID: 10910074
    [Abstract] [Full Text] [Related]

  • 5. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ.
    Laryngoscope; 2002 Dec 01; 112(12):2129-40. PubMed ID: 12461330
    [Abstract] [Full Text] [Related]

  • 6. [The molecular marker eIF4E in the surgical margins of the resection preparations of head-neck tumors as a prognostic factor].
    Ernst-Stecken A.
    Strahlenther Onkol; 2000 Aug 01; 176(8):383-4. PubMed ID: 10987024
    [No Abstract] [Full Text] [Related]

  • 7. An Australian retrospective study to evaluate the prognostic role of p53 and eIF4E cancer markers in patients with head and neck squamous cell carcinoma (HNSCC): study protocol.
    Singh J, Jayaraj R, Baxi S, Mileva M, Curtin J, Thomas M.
    Asian Pac J Cancer Prev; 2013 Aug 01; 14(8):4717-21. PubMed ID: 24083732
    [Abstract] [Full Text] [Related]

  • 8. Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer.
    Sunavala-Dossabhoy G, Palaniyandi S, Clark C, Nathan CO, Abreo FW, Caldito G.
    Laryngoscope; 2011 Oct 01; 121(10):2136-41. PubMed ID: 21898433
    [Abstract] [Full Text] [Related]

  • 9. Outcome of Patients With Head and Neck Squamous Cell Carcinoma Can be Predicted by Expression of eIF4E and Osteopontin in Free Surgical Margins.
    Abouhashem NS, Elwan A, Elaidy NF.
    Appl Immunohistochem Mol Morphol; 2011 Oct 01; 30(5):e40-e49. PubMed ID: 35285458
    [Abstract] [Full Text] [Related]

  • 10. Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers.
    Sorrells DL, Ghali GE, De Benedetti A, Nathan CO, Li BD.
    J Oral Maxillofac Surg; 1999 Mar 01; 57(3):294-9. PubMed ID: 10077200
    [Abstract] [Full Text] [Related]

  • 11. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
    van Houten VM, Leemans CR, Kummer JA, Dijkstra J, Kuik DJ, van den Brekel MW, Snow GB, Brakenhoff RH.
    Clin Cancer Res; 2004 Jun 01; 10(11):3614-20. PubMed ID: 15173067
    [Abstract] [Full Text] [Related]

  • 12. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Nathan CO, Amirghahari N, Abreo F, Rong X, Caldito G, Jones ML, Zhou H, Smith M, Kimberly D, Glass J.
    Clin Cancer Res; 2004 Sep 01; 10(17):5820-7. PubMed ID: 15355912
    [Abstract] [Full Text] [Related]

  • 13. Predictability of Recurrence using Immunohistochemistry to delineate Surgical Margins in mucosal Head and Neck Squamous Cell Carcinoma (PRISM-HNSCC): study protocol for a prospective, observational and bilateral study in Australia and India.
    Joseph S, Janakiraman R, Chacko G, Jayaraj R, Thomas M, Thomas M, Mukhopadhyay S.
    BMJ Open; 2017 Oct 15; 7(10):e014824. PubMed ID: 29038175
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients.
    de Carvalho AC, Kowalski LP, Campos AH, Soares FA, Carvalho AL, Vettore AL.
    Oral Oncol; 2012 Mar 15; 48(3):240-8. PubMed ID: 22104250
    [Abstract] [Full Text] [Related]

  • 15. Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome.
    Li BD, Gruner JS, Abreo F, Johnson LW, Yu H, Nawas S, McDonald JC, DeBenedetti A.
    Ann Surg; 2002 May 15; 235(5):732-8; discussion 738-9. PubMed ID: 11981220
    [Abstract] [Full Text] [Related]

  • 16. Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor.
    Sorrells DL, Meschonat C, Black D, Li BD.
    J Surg Res; 1999 Jul 15; 85(1):37-42. PubMed ID: 10383835
    [Abstract] [Full Text] [Related]

  • 17. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.
    Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, Goodman SN, Sidransky D.
    N Engl J Med; 1995 Feb 16; 332(7):429-35. PubMed ID: 7619114
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical expression levels of p53 and eIF4E markers in histologically negative surgical margins, and their association with the clinical outcome of patients with head and neck squamous cell carcinoma.
    Singh J, Jayaraj R, Baxi S, Mileva M, Skinner J, Dhand NK, Thomas M.
    Mol Clin Oncol; 2016 Feb 16; 4(2):166-172. PubMed ID: 26893854
    [Abstract] [Full Text] [Related]

  • 19. Biological tailoring of adjuvant radiotherapy in head and neck and oral malignancies - The potential role of p53 and eIF4E as predictive parameters.
    Joseph B, Kumar RV, Champaka G, Shenoy A, Sabitha KS, Lokesh V, Ramesh C, Vijay CR.
    Indian J Cancer; 2019 Feb 16; 56(4):330-334. PubMed ID: 31607702
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of cyclin D1 expression in tumor-free surgical margins in head and neck squamous cell carcinomas.
    Sakashita T, Homma A, Suzuki S, Hatakeyama H, Kano S, Mizumachi T, Oridate N, Fukuda S.
    Acta Otolaryngol; 2013 Sep 16; 133(9):984-91. PubMed ID: 23692432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.